Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 501–600 of 1,020
A multicentre collaboration to investigate the cause of severe acute respiratory syndrome
Stöhr, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13376-4 · Cited by 186
Zhang, L., Zhang, F., Yu, W., He, T., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 186
The aetiology, origins, and diagnosis of severe acute respiratory syndrome
Poon, L., Guan, Y., Nicholls, J., Yuen, K., & Peiris, J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01172-7 · Cited by 184
Understanding Human Coronavirus HCoV-NL63~!2009-11-13~!2010-04-09~!2010-05-25~!
Abdul-Rasool, S., & Fielding, B. C. (2010) · The Open Virology Journal · doi:10.2174/1874357901004010076 · Cited by 184
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak
Sung, J. J. Y. (2004) · Thorax · doi:10.1136/thx.2003.014076 · Cited by 185
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Yang, H., Bartlam, M., & Rao, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010369 · Cited by 185
Li, G.-M., Li, Y.-G., Yamate, M., Li, S.-M., & Ikuta, K. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2006.10.015 · Cited by 185
Overview on SARS in Asia and the World
LAM, W., ZHONG, N., & TAN, W. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00516.x · Cited by 179
Comparative Analysis of Primer–Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2)
Jung, Y., Park, G.-S., Moon, J. H., Ku, K., Beak, S.-H., Lee, C.-S., Kim, S., Park, E. C., Park, D., Lee, J.-H., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00464 · Cited by 184
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Alsoussi, W. B., Turner, J. S., Case, J. B., Zhao, H., Schmitz, A. J., Zhou, J. Q., Chen, R. E., Lei, T., Rizk, A. A., McIntire, K. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000583 · Cited by 181
Tan, J., Verschueren, K. H. G., Anand, K., Shen, J., Yang, M., Xu, Y., Rao, Z., Bigalke, J., Heisen, B., Mesters, J. R., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.012 · Cited by 184
Memish, Z. A., Al-Tawfiq, J. A., Makhdoom, H. Q., Assiri, A., Alhakeem, R. F., Albarrak, A., Alsubaie, S., Al-Rabeeah, A. A., Hajomar, W. H., Hussain, R., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu292 · Cited by 182
Self-citationSynthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
Chen, L.-R., Wang, Y.-C., Lin, Y. W., Chou, S.-Y., Chen, S.-F., Liu, L. T., Wu, Y.-T., Kuo, C.-J., Chen, T. S.-S., & Juang, S.-H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.027 · Cited by 180
Simulating the SARS outbreak in Beijing with limited data
Wang, W., & Ruan, S. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.11.014 · Cited by 183
Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., He, T., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 183
Possible environmental effects on the spread of COVID-19 in China
Xu, H., Yan, C., Fu, Q., Xiao, K., Yu, Y., Han, D., Wang, W., & Cheng, J. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139211 · Cited by 183
A prospective clinical study of detailed neurological manifestations in patients with COVID-19
Karadaş, Ö., Öztürk, B., & Sonkaya, A. R. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04547-7 · Cited by 184
Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan
Twu, S.-J., Chen, T.-J., Chen, C.-J., Olsen, S. J., Lee, L.-T., Fisk, T., Hsu, K.-H., Chang, S.-C., Chen, K.-T., Chiang, I.-H., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.030283 · Cited by 179
Controlling Cytokine Storm Is Vital in COVID-19
Tang, L., Yin, Z., Hu, Y., & Mei, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570993 · Cited by 183
The chronology of the 2002–2003 SARS mini pandemic
Cherry, J. D. (2004) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2004.07.009 · Cited by 169
Roper, R. L., & Rehm, K. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.43 · Cited by 180
Marsden, P. A., Ning, Q., Fung, L. S., Luo, X., Chen, Y., Mendicino, M., Ghanekar, A., Scott, J. A., Miller, T., Chan, C. W. Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18114 · Cited by 180
Tan, Y.-J., Goh, P.-Y., Fielding, B. C., Shen, S., Chou, C.-F., Fu, J.-L., Leong, H. N., Leo, Y. S., Ooi, E. E., Ling, A. E., et al. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.2.362-371.2004 · Cited by 180
Blume, C., Jackson, C. L., Spalluto, C. M., Legebeke, J., Nazlamova, L., Conforti, F., Perotin, J.-M., Frank, M., Butler, J., Crispin, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00759-x · Cited by 180
Analysis of multimerization of the SARS coronavirus nucleocapsid protein
He, R., Dobie, F., Ballantine, M., Leeson, A., Li, Y., Bastien, N., Cutts, T., Andonov, A., Cao, J., Booth, T. F., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.074 · Cited by 179
Human Coronavirus 229E Binds to CD13 in Rafts and Enters the Cell through Caveolae
Nomura, R., Kiyota, A., Suzaki, E., Kataoka, K., Ohe, Y., Miyamoto, K., Senda, T., & Fujimoto, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8701-8708.2004 · Cited by 180
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Liu, Y., Liang, C., Xin, L., Ren, X., Tian, L., Ju, X., Li, H., Wang, Y., Zhao, Q., Liu, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112711 · Cited by 170
Tanner, J. A., Zheng, B.-J., Zhou, J., Watt, R. M., Jiang, J.-Q., Wong, K.-L., Lin, Y.-P., Lu, L.-Y., He, M.-L., Kung, H.-F., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.01.006 · Cited by 176
Human Coronavirus NL63 and 229E Seroconversion in Children
Dijkman, R., Jebbink, M. F., El Idrissi, N. B., Pyrc, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L., & van der Hoek, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-08 · Cited by 185
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic
Graham, B. S., & Sullivan, N. J. (2018) · Nature Immunology · doi:10.1038/s41590-017-0007-9 · Cited by 175
To, K., Tong, J. H., Chan, P. K., Au, F. W., Chim, S. S., Allen Chan, K., Cheung, J. L., Liu, E. Y., Tse, G. M., Lo, A. W., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1510 · Cited by 177
Moës, E., Vijgen, L., Keyaerts, E., Zlateva, K., Li, S., Maes, P., Pyrc, K., Berkhout, B., van der Hoek, L., & Van Ranst, M. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-6 · Cited by 177
Potential antivirals and antiviral strategies against SARS coronavirus infections
De Clercq, E. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.291 · Cited by 176
Lee, T.-W., Cherney, M. M., Huitema, C., Liu, J., James, K. E., Powers, J. C., Eltis, L. D., & James, M. N. G. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.004 · Cited by 170
Structural basis for broad coronavirus neutralization
Sauer, M. M., Tortorici, M. A., Park, Y.-J., Walls, A. C., Homad, L., Acton, O. J., Bowen, J. E., Wang, C., Xiong, X., de van der Schueren, W., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00596-4 · Cited by 187
Severe Acute Respiratory Syndrome (SARS) and Healthcare Workers
Chan-Yeung, M. (2004) · International Journal of Occupational and Environmental Health · doi:10.1179/oeh.2004.10.4.421 · Cited by 175
SAIF, L. J. (2004) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.23.2.1513 · Cited by 177
Schaecher, S. R., Mackenzie, J. M., & Pekosz, A. (2007) · Journal of Virology · doi:10.1128/jvi.01691-06 · Cited by 176
Lin, L., Hanson, C. V., Alter, H. J., Jauvin, V., Bernard, K. A., Murthy, K. K., Metzel, P., & Corash, L. (2005) · Transfusion · doi:10.1111/j.0041-1132.2005.04316.x · Cited by 172
“In recent years, the most important examples of emerging viruses have been WNV, introduced into North America, and SARS virus, reported in Asia.46 Vaccinia virus, a model for smallpox virus, is of interest because the blood supply could represent a soft target for bioterrorists.”
BackgroundKim, T. W., Lee, J. H., Hung, C.-F., Peng, S., Roden, R., Wang, M.-C., Viscidi, R., Tsai, Y.-C., He, L., Chen, P.-J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4638-4645.2004 · Cited by 173
Park, J.-Y., Jae Jeong, H., Hoon Kim, J., Min Kim, Y., Park, S.-J., Kim, D., Hun Park, K., Song Lee, W., & Bae Ryu, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00623 · Cited by 170
Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China
Wang, X., Zhou, Q., He, Y., Liu, L., Ma, X., Wei, X., Jiang, N., Liang, L., Zheng, Y., Ma, L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00544-2020 · Cited by 174
Cao, J., Forrest, J. C., & Zhang, X. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.11.010 · Cited by 169
Kuate, S., Cinatl, J., Doerr, H. W., & Überla, K. (2007) · Virology · doi:10.1016/j.virol.2006.12.011 · Cited by 167
Self-citationRisk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China
Wu, J., Xu, F., Zhou, W., Feikin, D. R., Lin, C.-Y., He, X., Zhu, Z., Liang, W., Chin, D. P., & Schuchat, A. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030730 · Cited by 173
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Trovato, M., Sartorius, R., D’Apice, L., Manco, R., & De Berardinis, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02130 · Cited by 169
Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV
Li, X., Zai, J., Wang, X., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25693 · Cited by 170
Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
Monto, A. S., DeJonge, P. M., Callear, A. P., Bazzi, L. A., Capriola, S. B., Malosh, R. E., Martin, E. T., & Petrie, J. G. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa161 · Cited by 170
Pathogenesis of severe acute respiratory syndrome
Lau, Y. L., & Peiris, J. M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168
Yam, W. C., Chan, K. H., Poon, L. L. M., Guan, Y., Yuen, K. Y., Seto, W. H., & Peiris, J. S. M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4521-4524.2003 · Cited by 169
Yang, S., Chen, S.-J., Hsu, M.-F., Wu, J.-D., Tseng, C.-T. K., Liu, Y.-F., Chen, H.-C., Kuo, C.-W., Wu, C.-S., Chang, L.-W., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603926 · Cited by 161
Severe Acute Respiratory Syndrome (SARS): A Year in Review
Skowronski, D. M., Astell, C., Brunham, R. C., Low, D. E., Petric, M., Roper, R. L., Talbot, P. J., Tam, T., & Babiuk, L. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.091103.134135 · Cited by 173
Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus
Farcas, G. A., Poutanen, S. M., Mazzulli, T., Willey, B. M., Butany, J., Asa, S. L., Faure, P., Akhavan, P., Low, D. E., & Kain, K. C. (2005) · The Journal of Infectious Diseases · doi:10.1086/426870 · Cited by 167
Lin, J.-T., Zhang, J.-S., Su, N., Xu, J.-G., Wang, N., Chen, J.-T., Chen, X., Liu, Y.-X., Gao, H., Jia, Y.-P., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200702 · Cited by 167
Sekimukai, H., Iwata‐Yoshikawa, N., Fukushi, S., Tani, H., Kataoka, M., Suzuki, T., Hasegawa, H., Niikura, K., Arai, K., & Nagata, N. (2020) · Microbiology and Immunology · doi:10.1111/1348-0421.12754 · Cited by 170
Programmed ribosomal frameshifting in HIV-1 and the SARS–CoV
Brierley, I., & Dos Ramos, F. J. (2006) · Virus Research · doi:10.1016/j.virusres.2005.10.008 · Cited by 173
De Albuquerque, N., Baig, E., Ma, X., Zhang, J., He, W., Rowe, A., Habal, M., Liu, M., Shalev, I., Downey, G. P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00747-06 · Cited by 170
Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
Zhuang, M., Jiang, H., Suzuki, Y., Li, X., Xiao, P., Tanaka, T., Ling, H., Yang, B., Saitoh, H., Zhang, L., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.02.001 · Cited by 168
Li, W., Greenough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M., & Choe, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11429-11433.2004 · Cited by 171
Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells
Mizutani, T., Fukushi, S., Saijo, M., Kurane, I., & Morikawa, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.107 · Cited by 170
Zhou, Y., Lu, K., Pfefferle, S., Bertram, S., Glowacka, I., Drosten, C., Pöhlmann, S., & Simmons, G. (2010) · Journal of Virology · doi:10.1128/jvi.00554-10 · Cited by 167
Self-citationShrikrishna, D., Coker, R. K., & on behalf of the Air Travel Working Party of the British Thoracic Society Standards of Care Committee (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200694 · Cited by 167
Tümsekçalı, E., Ayyıldız, E., & Taskin, A. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.115757 · Cited by 179
Breitbart, M., & Rohwer, F. (2005) · BioTechniques · doi:10.2144/000112019 · Cited by 167
Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication
Chen, C.-J., Michaelis, M., Hsu, H.-K., Tsai, C.-C., Yang, K. D., Wu, Y.-C., Cinatl, J., & Doerr, H. W. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.048 · Cited by 165
Self-citationInterleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
Li, L., Li, J., Gao, M., Fan, H., Wang, Y., Xu, X., Chen, C., Liu, J., Kim, J., Aliyari, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602395 · Cited by 164
Coronavirus nucleocapsid protein is an RNA chaperone
Zúñiga, S., Sola, I., Moreno, J. L., Sabella, P., Plana-Durán, J., & Enjuanes, L. (2007) · Virology · doi:10.1016/j.virol.2006.07.046 · Cited by 165
SARS and Pregnancy: A Case Report
Robertson, C. A., Lowther, S. A., Birch, T., Tan, C., Sorhage, F. E., Stockman, L. J., McDonald, L. C., Lingappa, J. R., & Bresnitz, E. A. (2004) · Emerging infectious diseases · doi:10.3201/eid1002.030736 · Cited by 176
SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Citarella, A., Scala, A., Piperno, A., & Micale, N. (2021) · Biomolecules · doi:10.3390/biom11040607 · Cited by 182
Identification of New Respiratory Viruses in the New Millennium
Berry, M., Gamieldien, J., & Fielding, B. (2015) · Viruses · doi:10.3390/v7030996 · Cited by 162
Wen, C.-C., Shyur, L.-F., Jan, J.-T., Liang, P.-H., Kuo, C.-J., Arulselvan, P., Wu, J.-B., Kuo, S.-C., & Yang, N.-S. (2011) · Journal of Traditional and Complementary Medicine · doi:10.1016/s2225-4110(16)30055-4 · Cited by 161
COVID-19 – what should anaethesiologists and intensivists know about it?
Wujtewicz, M. A., Dylczyk-Sommer, A., Aszkiełowicz, A., Zdanowski, S., Piwowarczyk, S., & Owczuk, R. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.93756 · Cited by 160
Genomic Epidemiology, Evolution, and Transmission Dynamics of Porcine Deltacoronavirus
He, W.-T., Ji, X., He, W., Dellicour, S., Wang, S., Li, G., Zhang, L., Gilbert, M., Zhu, H., Xing, G., et al. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa117 · Cited by 163
McCallum, M., Walls, A. C., Bowen, J. E., Corti, D., & Veesler, D. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0483-8 · Cited by 173
Breathing, speaking, coughing or sneezing: What drives transmission of SARS‐CoV‐2?
Stadnytskyi, V., Anfinrud, P., & Bax, A. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13326 · Cited by 162
Peng, T., Lee, K., & Tarn, W. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06564.x · Cited by 167
Lu, I.-L., Mahindroo, N., Liang, P.-H., Peng, Y.-H., Kuo, C.-J., Tsai, K.-C., Hsieh, H.-P., Chao, Y.-S., & Wu, S.-Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060207o · Cited by 161
Boukhatem, M. N., & Setzer, W. N. (2020) · Plants · doi:10.3390/plants9060800 · Cited by 179
Ulasli, M., Gurses, S. A., Bayraktar, R., Yumrutas, O., Oztuzcu, S., Igci, M., Igci, Y. Z., Cakmak, E. A., & Arslan, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3019-7 · Cited by 162
Yang, Y., Xiong, Z., Zhang, S., Yan, Y., Nguyen, J., Ng, B., Lu, H., Brendese, J., Yang, F., Wang, H., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050698 · Cited by 162
Keyaerts, E., Vijgen, L., Chen, L., Maes, P., Hedenstierna, G., & Van Ranst, M. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.04.012 · Cited by 161
Shahzad, F., Shahzad, U., Fareed, Z., Iqbal, N., Hashmi, S. H., & Ahmad, F. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139115 · Cited by 161
Jonassen, C. M., Kofstad, T., Larsen, I.-L., Løvland, A., Handeland, K., Follestad, A., & Lillehaug, A. (2005) · Journal of General Virology · doi:10.1099/vir.0.80927-0 · Cited by 163
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
DeDiego, M. L., Pewe, L., Alvarez, E., Rejas, M. T., Perlman, S., & Enjuanes, L. (2008) · Virology · doi:10.1016/j.virol.2008.03.005 · Cited by 161
Laboratory Systems and Services Are Critical in Global Health: Time to End the Neglect?
Nkengasong, J. N., Nsubuga, P., Nwanyanwu, O., Gershy-Damet, G.-M., Roscigno, G., Bulterys, M., Schoub, B., DeCock, K. M., & Birx, D. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpmpsinq9brmu6 · Cited by 160
Ren, W., Qu, X., Li, W., Han, Z., Yu, M., Zhou, P., Zhang, S.-Y., Wang, L.-F., Deng, H., & Shi, Z. (2008) · Journal of Virology · doi:10.1128/jvi.01085-07 · Cited by 161
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
Kuo, C.-J., Chi, Y.-H., Hsu, J. T.-A., & Liang, P.-H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.098 · Cited by 158
Surface vimentin is critical for the cell entry of SARS-CoV
Yu, Y. T.-C., Chien, S.-C., Chen, I.-Y., Lai, C.-T., Tsay, Y.-G., Chang, S. C., & Chang, M.-F. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0234-7 · Cited by 163
Zielecki, F., Weber, M., Eickmann, M., Spiegelberg, L., Zaki, A. M., Matrosovich, M., Becker, S., & Weber, F. (2013) · Journal of Virology · doi:10.1128/jvi.03496-12 · Cited by 158
Self-citationQu, X.-X., Hao, P., Song, X.-J., Jiang, S.-M., Liu, Y.-X., Wang, P.-G., Rao, X., Song, H.-D., Wang, S.-Y., Zuo, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500662200 · Cited by 161
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158
“On initial isolation of SARS-CoV from infected patients, it was identified as a novel Group 2 Coronavirus and the genetic mechanisms governing the increased pathogenicity of the virus remain undefined [1,2].”
Backgroundvan den Brand, J. M. A., Haagmans, B. L., van Riel, D., Osterhaus, A. D. M. E., & Kuiken, T. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.01.004 · Cited by 160
Self-citationSibley, C. D., Peirano, G., & Church, D. L. (2012) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2012.01.011 · Cited by 159
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results
Caruana, G., Croxatto, A., Coste, A. T., Opota, O., Lamoth, F., Jaton, K., & Greub, G. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.019 · Cited by 160
Chan, K.-H., Chan, J. F.-W., Tse, H., Chen, H., Lau, C. C.-Y., Cai, J.-P., Tsang, A. K.-L., Xiao, X., To, K. K.-W., Lau, S. K.-P., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.03.015 · Cited by 160
SARS in Hospital Emergency Room
Chen, Y.-C., Huang, L.-M., Chan, C.-C., Su, C.-P., Chang, S.-C., Chang, Y.-Y., Chen, M.-L., Hung, C.-C., Chen, W.-J., Lin, F.-Y., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030579 · Cited by 159
Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication
Sakai, Y., Kawachi, K., Terada, Y., Omori, H., Matsuura, Y., & Kamitani, W. (2017) · Virology · doi:10.1016/j.virol.2017.07.019 · Cited by 158
Expanding the RNA Virosphere by Unbiased Metagenomics
Zhang, Y.-Z., Chen, Y.-M., Wang, W., Qin, X.-C., & Holmes, E. C. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015851 · Cited by 157
COVID-19: Progress in diagnostics, therapy and vaccination
Liu, X., Liu, C., Liu, G., Luo, W., & Xia, N. (2020) · Theranostics · doi:10.7150/thno.47987 · Cited by 169
Emerging Respiratory Viruses: Challenges and Vaccine Strategies
Gillim-Ross, L., & Subbarao, K. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-06 · Cited by 175
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.